MobiHealthNews covered Fesarius Therapeutics' $20 million Series A and its plans to expand DermiSphere™ hDRT, the company's dermal repair technology.
MobiHealthNews: FesariusTherapeutics Raises $20M to Expand Dermal Repair Technology
MobiHealthNews covered Fesarius Therapeutics' $20 million Series A and its plans to expand DermiSphere™ hDRT, the company's dermal repair technology.